Status: technology licensed off
Pyrosequencing AB developed the sequencing chemistry from which it took its name. In 2003 they acquired Biotage and changed their name to that of the acquired company. Biotage was later sold to Qiagen who has licensed the pyrosequencing technology exclusively to 454 (now Roche) for high density/high throughput sequencing applications.
Please contact us at firstname.lastname@example.org if you have any information or opinions you’d like to share about this page.